T2 Biosystems

Ticker: TTOO

Sector: Biotechnology

T2 Biosystems

Latest SEC filings for t2 biosystems, inc. (ttoo) latest sec filings. Latest SEC files for T2 Biosystems,. Inc. (TTOO) have the 128th highest Short-Term Technical score. T2 Biosystems to participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. The company is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. T2 Biosystems tests are designed to help clinicians diagnose sepsis more quickly and accurately. Sepsis is a life-threatening condition that occurs when the bodys response to an infection damages its own tissues and organs. The short-term trends surrounding the T2 t2 biosystems reports granting of inducement award. t2 is above $1 and the main concern for the buyers will be to keep the T2 Biosystems stock above. $1 for 10 consecutive trading days. T2 Biosystems, Inc. (NASDAQ:TTOO) stock price today is $5.42, and todays volume is 440,143. T2 biosystems is an emerging leader in the field of in vitro diagnostics. T2 Biosystems regains compliance with Nasdaq listing requirement - tipranks.com. Try Now>> See todays best-performing stocks on TipRanks. T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact - Micro Cap Daily. T2Biothreat is the exclusive FDA-cleared product capable of achieving 100% accurate sepsis detection. T2 Biosystems does not appear to pay any dividends at this time. The average price target for T2Biosystems is $7.00, which is 29.39%.